Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: A modelling study
Journal article published in Human Vaccines & Immunotherapeutics and co-authored by PATH's Frédéric Debellut, Clint Pecenka, and Bill Hausdorff.
Publication date: November 2022